Accrol Group Holdings results and investor presentation 2nd September

Accrol paper
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that its Audited Final Results for the year ended 30 April 2020 will be published on Wednesday, 2 September 2020.

Investor Meet Company Presentation

Accrol is committed to communicating with all investors equally and directly, to ensure that its strategy, business model and performance are clearly understood. Accordingly, a part of the Group’s Final Results roadshow, an online presentation for all interested parties will be hosted by management via the Investor Meet Company (“IMC”) platform. This will take place at 13.15 hours on Friday, 4 September 2020.

To participate, you must register with IMC at https://www.investormeetcompany.com/accrol-group-holdings-plc/register-investor. Those who have already registered interest in Accrol Group Holdings with IMC will be invited automatically.

Questions may be submitted ahead of the event, through the IMC dashboard, or at any time during the live presentation, via the “Ask a Question” function. Whilst the management may not be in a position to answer all questions, the team will endeavour to answer the most pertinent ones within the confines of the information already disclosed to the market.

The presentation and Q&A responses will be available on the IMC platform at the earliest opportunity post-event.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search